Investor Relations (IR) Questions: Amarantus BioScience AMBS
Click here to return to the biotech IRQ Index
Answers received: February 2013
1) When is the last time AMBS raised cash through an offering (diluted)?
January 31st thru a funding commitment via a convertible note with Dominion Capital:
http://ir.stockpr.com/amarantus/company-news/detail/543
2) How much cash (not cash equivalents) does AMBS have?
$1.4 million
3) What and approximately when is the next known catalyst?
Initiation of diagnostic studies in 2013
4) What is AMBS's quarterly cash burn?
$50,000 per month with expected increase for study initiations
5) Does AMBS have an existing line of credit and if so how much can they draw against it?
No.
1) When is the last time AMBS raised cash through an offering (diluted)?
January 31st thru a funding commitment via a convertible note with Dominion Capital:
http://ir.stockpr.com/amarantus/company-news/detail/543
2) How much cash (not cash equivalents) does AMBS have?
$1.4 million
3) What and approximately when is the next known catalyst?
Initiation of diagnostic studies in 2013
4) What is AMBS's quarterly cash burn?
$50,000 per month with expected increase for study initiations
5) Does AMBS have an existing line of credit and if so how much can they draw against it?
No.